Intensitya | Group I accelerated (N = 61) | Group II conventional (N = 61) | |
---|---|---|---|
Systemic reaction | Mild | 8 (13.1 %) | 2 (3.3 %) |
Moderate | 0 (0.0 %) | 2 (3.3 %) | |
Severe | 0 (0.0 %) | 0 (0.0 %) | |
Injection site swelling | Mild | 10 (16.4 %) | 5 (8.2 %) |
Moderate | 2 (3.3 %) | 1 (1.6 %) | |
Severe | 1 (1.6 %) | 0 (0.0 %) | |
Injection site erythema | Mild | 10 (16.4 %) | 7 (11.5 %) |
Moderate | 1 (1.6 %) | 0 (0.0 %) | |
Severe | 0 (0.0 %) | 0 (0.0 %) |